Professor Mullins’ research and teaching focus on community-engaged, patient-centered comparative effectiveness research to advance health equity. He has received funding as Principal Investigator from the Agency for Healthcare Research and Quality (AHRQ), the Food and Drug Administration (through its CERSI initiative), National Institute on Aging (NIA), the Patient-Centered Outcomes Research Institute (PCORI), various pharmaceutical manufacturers including Bayer, Merck, and Pfizer, patient advocacy organizations, and the insurance industry. For more information on Professor Mullins’ research projects, please see the Research Projects section.